PBPK modeling of ivermectin—Considerations for the purpose of developing alternative routes to optimize its safety profile
Abstract Although single‐dose ivermectin has been widely used in mass‐drug administration programs for onchocerciasis and lymphatic filariasis for many years, ivermectin may have utility as an endectocide with mosquito‐lethal effects at dosages greater and longer than those used to treat helminths....
Main Authors: | Karen Rowland Yeo, David Wesche |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12950 |
Similar Items
-
Development and application of a PBPK modeling strategy to support antimalarial drug development
by: Nada Abla, et al.
Published: (2023-09-01) -
PBPK perspective on alternative CYP3A4 inducers for rifampin
by: Kuan‐Fu Chen, et al.
Published: (2022-12-01) -
Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example
by: Xian Pan, et al.
Published: (2024-03-01) -
Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling
by: J. Porter Hunt, et al.
Published: (2024-04-01) -
Ivermectin: Evaluation of Efficacy and Safety in COVID-19
by: E. V. Shubnikova, et al.
Published: (2022-04-01)